Powered by

Immunovaccine falls for a second consecutive day, a two-day fall of 1.2% January 09, 2019 17:00 EST

Jan 09, 2019 - News Bites Canadian Markets


Immunovaccine Inc. (TSX:IMV), Canada's 8th largest Biotechnology company by market cap, has fallen 2.0c (0.3%) for a second consecutive day on Wednesday. This brought its two-day fall to 9.0c (1.2%), compared with the S&P/TSX 60 Index which rose 17.4 points (2.0%) in the two days for a relative price change of -3.2%. Cumulative volume in the 2 days was 0.6 times the average 2-day volume of 38,403 shares. Immunovaccine's stock last traded at CAD7.15. Its MCap is ...